Guardant Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers the results of the Annual Meeting of Stockholders held on June 17, 2026. The filing details the voting outcomes for director elections, auditor ratification, and executive compensation proposals.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
- Director Elections (Proposal 1): All nominees were elected. Manuel Hidalgo Medina received the highest support with 81,925,123 votes for, while Ian Clark received 70,526,891 votes for.
- Auditor Ratification (Proposal 2): The selection of Deloitte & Touche LLP as the independent registered public accounting firm for the year ending December 31, 2026, was approved with 115,899,030 votes for.
- Executive Compensation (Proposal 3): The advisory vote to approve the compensation of named executive officers was not approved. Votes against (9,905,190) exceeded votes for (98,236,639) in terms of opposition relative to the total vote count, though the "For" votes were numerically higher, the filing explicitly states the proposal was not approved.
- Compensation Vote Frequency (Proposal 4): Stockholders voted to hold future advisory votes on executive compensation annually, with 107,997,996 votes cast for a one-year frequency.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary, risks, contingencies, or unusual items. The failure of Proposal 3 indicates significant shareholder dissatisfaction with current executive compensation practices, which may lead to management review or changes in future compensation structures.
Key Facts for Investor Verification
- Verify the specific reasons cited by management for the failure of the executive compensation advisory vote (Proposal 3).
- Review the Definitive Proxy Statement filed on April 28, 2026, for details on the compensation packages that were rejected.
- Monitor upcoming announcements regarding potential changes to executive compensation policies or board composition in response to the voting results.
- Confirm the total number of shares outstanding to calculate the percentage of votes withheld or cast against proposals.